Medical devices and equipmentMedtronic must face shareholder over infuse | Reuters
A U.S. federal appeals court on Wednesday revived a lawsuit accusing Medtronic Plc of defrauding shareholders by covering up negative side effects from its Infuse bone growth product.
PharmaceuticalsTeva settles foreign corruption probe for $519 million | The Wall Street Journal
Teva Pharmaceutical Industries agreed to pay $519 million to settle U.S. charges that it violated U.S. foreign-bribery law in its operations in Ukraine, Mexico and Russia.
Medicare pays for a kidney transplant, but not the drugs to keep it viable | Kaiser Health News
The federal government will pay more than $100,000 to give someone a kidney transplant, but after three years, the government will often stop paying for the drugs needed to keep that transplanted kidney alive.
Safety, quality and clinical practiceAfter weight-loss surgery, a year of joys and disappointments | The New York Times
Nearly 200,000 Americans have bariatric surgery each year. Most people believe that the operation simply forces people to eat less by making their stomachs smaller, but scientists have discovered that it actually causes profound changes in patients’ physiology, altering the activity of thousands of genes in the human body as well as the complex hormonal signaling from the gut to the brain.
Millions of U.S. children with special needs receive care from family members that would cost billions of dollars if it was instead provided by home health aides receiving minimum wage, a recent study suggests.